These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36052665)

  • 1. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Kim WR; Mannalithara A; Kwo PY; Bonham CA; Kwong A
    Hepatology; 2023 Mar; 77(3):851-861. PubMed ID: 36052665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.
    Miyake K; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Gonzalez HC; Venkat D; Moonka D; Yoshida A; Abouljoud MS; Nagai S
    Transplantation; 2024 Sep; 108(9):1943-1953. PubMed ID: 38409687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD 3.0 for adolescent liver transplant candidates.
    Kwong AJ; Zhang KY; Ebel N; Mannalithara A; Kim WR
    Hepatology; 2023 Aug; 78(2):540-546. PubMed ID: 36943091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.
    Ishaque T; Kernodle AB; Motter JD; Jackson KR; Chiang TP; Getsin S; Boyarsky BJ; Garonzik-Wang J; Gentry SE; Segev DL; Massie AB
    Am J Transplant; 2021 Oct; 21(10):3305-3311. PubMed ID: 33870635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.